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Abstract
Osteocytes are terminally differentiated osteoblasts which reside in a mineralized extracellular matrix (ECM). The factors that
regulate this differentiation process are unknown. We have investigated whether ECM mineralization could promote
osteocyte formation. To do this we have utilised MLO-A5 pre-osteocyte-like cells and western blotting and comparative RT-
PCR to examine whether the expression of osteocyte-selective markers is elevated concurrently with the onset of ECM
mineralization. Secondly, if mineralization of the ECM is indeed a driver of osteocyte formation, we reasoned that
impairment of ECM mineralization would result in a reversible inhibition of osteocyte formation. Supplementation of MLO-
A5 cell cultures with ascorbic acid and phosphate promoted progressive ECM mineralization as well as temporally
associated increases in expression of the osteocyte-selective markers, E11/gp38 glycoprotein and sclerostin. Consistent with
a primary role for ECM mineralization in osteocyte formation, we also found that inhibition of ECM mineralization, by
omitting phosphate or adding sodium pyrophosphate, a recognized inhibitor of hydroxyapatite formation, resulted in a 15-
fold decrease in mineral deposition that was closely accompanied by lower expression of E11 and other osteocyte markers
such as Dmp1, Cd44 and Sost whilst expression of osteoblast markers Ocn and Col1a increased. To rule out the possibility
that such restriction of ECM mineralization may produce an irreversible modification in osteoblast behaviour to limit E11
expression and osteocytogenesis, we also measured the capacity of MLO-A5 cells to re-enter the osteocyte differentiation
programme. We found that the mineralisation process was re-initiated and closely allied to increased expression of E11
protein after re-administration of phosphate or omission of sodium pyrophosphate, indicating an ECM mineralization-
induced restoration in osteocyte formation. These results emphasise the importance of cell-ECM interactions in regulating
osteoblast behaviour and, more importantly, suggest that ECM mineralization exerts pivotal control during terminal
osteoblast differentiation and acquisition of the osteocyte phenotype.
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Introduction
Osteocytes are the most numerous cell type in bone. One of
their defining characteristics is the formation of multicellular
networks permeating the mineralized extracellular matrix (ECM),
through which they are believed to play pivotal mechanomodu-
latory roles in directing bone formation and bone resorption in
response to load-bearing [1]. Despite this crucial contribution to
bone remodelling, the mechanisms controlling osteocyte formation
from their osteoblast precursors remain largely undefined.
The process during which an osteoblast differentiates into an
osteocyte, termed osteocytogenesis, involves transition from the
cuboidal-like osteoblastic morphology to a dendritic shape
characteristic of an osteocyte, as it becomes embedded within
the bone ECM [2]. This is accompanied by a loss of cell volume,
reduced organelle content and the formation and elongation of
thin cytoplasmic projections. These projections pervade the bone
and, via the canaliculi, connect each osteocyte to its neighbours
within the bone ECM and to osteoblasts on the bone surface [2,3].
This transition from osteoblast to osteocyte is commonly
described to be a passive process, during which an osteoblast
destined for osteocytogenesis slows ECM production and becomes
surrounded by the osteoid synthesised by its neighbours [3–5].
Studies by Holmbeck et al. [6], however, show that cleavage of
collagen by MT1-MMP (membrane type 1 matrix metalloprotei-
nase), a membrane associated member of the MMP family, is
required for the development of osteocyte projections. Thus,
osteocytogenesis may be an active process involving activation of
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key pathways in specific osteoblasts to induce osteocytic differenti-
ation.
Many factors show altered expression during osteocytogenesis
[7]. Some factors such as SOST/sclerostin, which is specific to
osteocytes [8,9], regulate bone formation and inhibit osteoblast
differentiation by antagonising the Wnt-signalling pathway
[10,11]. Others, such as Phex (phosphate-regulating gene with
homologies to endopeptidases on the X chromosome) and Dmp1
(dentin matrix protein 1) have been shown to be involved in
phosphate homeostasis [12] and ECM mineralization [13,14],
another key feature of the osteoblast-osteocyte transition.
The E11/gp38 transmembrane glycoprotein is the earliest
osteocyte specific protein shown to be expressed during osteoblast-
to-osteocyte transition and therefore may be considered as an ideal
driver of this osteocytogenic process [15]. E11 is present in
osteocytes in the newly formed matrix (osteoid) as well as those in
the mineralized bone where its expression is increased in response to
fluid-flow shear stress [15,16]. Furthermore, siRNA E11 knockdown
abrogates the elongation of osteocyte processes in response to fluid-
flow sheer stress [15]. E11 is also expressed in kidney and lung where
it is alternatively known as podoplanin and T1alpha/RT140,
respectively [17–19]. By binding to members of the ERM (ezrin,
radixin, and moesin) family of proteins [18–20], E11 is implicated in
cytoskeletal re-arrangement and cell migration. The cell surface
glycoprotein CD44 is also expressed by osteocytes, but not
osteoblasts, in vivo [21]. Physical association of CD44 and E11 has
been observed in tumour vascular endothelial cells [22] and
squamous stratified epithelial cells [23] and similar interactions
may occur in osteocytes to influence cell morphology.
The extracellular environment, and in particular the ECM within
which cells become entombed, is also considered to exert a vital
influence during osteocytogenesis. Previous observations suggest
that the local ECM becomes mineralized concomitantly with
osteoblast-osteocyte differentiation [3,24] and studies by Irie et al.
[25] have shown that ECM mineralization is important for
maturation of immature rat osteocytes. These in vivo studies
demonstrated restricted formation of osteocyte dendritic projections
and reduced sclerostin expression in newly formed, non-mineralized
ECM of bisphosphonate-treated rats [25]. ECM mineralization
occurs when inorganic phosphate and calcium crystals (which
together form calcium-phosphate complexes and finally bone
hydroxyapatite: the inorganic component of bone) are deposited
along the type-I collagen fibrils, which comprise the ECM [26].
Thus, whilst it is well established that osteocytes within this
mineralized bone differ greatly in both morphology and gene and
protein expression compared to osteoblasts on the bone surface from
which they originated, the influence of ECM mineralization on
osteocyte differentiation remains to be fully elucidated.
In this study we have used the murine MLO-A5 cell line, which
both synthesizes a mineralized matrix and expresses osteocyte
markers [17,27] to examine the role of matrix mineralization
during osteocytogenic transition. Our studies indicate the
importance of ECM-cell interactions and the crucial role of
ECM mineralization as an essential regulator of osteocytogenesis.
Methods
MLO-A5 cell culture
The MLO-A5 murine pre-osteocyte cell line was obtained from
Lynda Bonewald (University of Missouri-Kansas City, USA). Cells
were plated at 356103 cells/cm2 in multi-well plates and cultured in
a-MEM medium supplemented with 5% (v/v) FBS, 5% (v/v) calf
serum (CS) (Invitrogen, Paisley UK) and 50 mg/ml gentamicin
(Invitrogen) (‘culture medium’) at 37uC with 5% CO2. At confluency
(day 0), the medium was changed to a-MEM supplemented with
10% FBS, 50 mg/ml gentamicin, 5 mM b-glycerol 2-phosphate
disodium salt hydrate (bGP, Sigma UK) and 100 mg/ml ascorbic
acid (AA, Sigma) in order to promote differentiation and matrix
mineralization (‘differentiation medium’). The MLO-A5 cells were
incubated at 37uC in a humidified atmosphere containing 5% CO2
and the medium was changed every 3 days for a further 15 days.
Individual cultures were collected at 3-day intervals for Alizarin red
staining for the assessment of matrix mineralization and for RNA
and protein extraction.
Primary calvarial osteoblast culture
Primary calvarial cells were isolated from 3 day-old C57Bl/6
mice as described in [28]. Briefly, excised calvaria were digested
with 1 mg/ml collagenase type II for 10 minutes to remove
fibroblasts and marrow cells. Calvaria were then digested with
1 mg/ml collagenase (30 minutes), 4 mM EDTA (10 minutes) and
1 mg/ml collagenase (30 minutes). The cells were collected from
each digest, resuspended in a-MEM supplemented with 10% FBS
and 50 mg/ml gentamicin and cultured at 37uC with 5% CO2
until confluent. For experiments, cells were seeded at a density of
1.56104 cells/cm2. At confluency (day 0), growth medium was
supplemented with 2.5 mM ßGP and 50 mg/ml AA for up to 28
days to induce ECM mineralization. The medium was changed
every second/third day.
Inhibition of MLO-A5 matrix mineralization
MLO-A5 cells were cultured as described and upon reaching
confluency the medium was changed to differentiation medium
lacking bGP (AA alone) or complete differentiation medium
supplemented with 500 mM sodium pyrophosphate (PPi) (Sigma);
found previously to be required in order to achieve full inhibition
of mineralization in MLO-A5 cell cultures (data not shown).
Medium was changed every 3 days and individual cultures were
collected at defined time points (see results). As a restriction of
Table 1. Primer sequences used for qRT-PCR.
Gene Source Sequence (59-39)
Phex (forward) PrimerDesign CTAACCACCACTCCCACTT
Phex (reverse) PrimerDesign CCAATAGACTCCAACCTGAAGA
E11 (forward) PrimerDesign AACAAGTCACCCCAATAGAGATAAT
E11 (reverse) PrimerDesign CTAACAAGACGCCAACTATGATTC
Cd44 (forward) PrimerDesign ATTGGATATGGTCTTGGTTTGGTA
Cd44 (reverse) PrimerDesign TGCCTCTTGGGTGGTGTTT
Akp2 (forward) PrimerDesign GGGACGAATCTCAGGGTACA
Akp2 (reverse) PrimerDesign AGTAACTGGGGTCTCTCTCTTT
Ocn (forward) PrimerDesign CCGGGAGCAGTGTGAGCTTA
Ocn (reverse) PrimerDesign TAGATGGGTTTGTAGGCGGTC
Col1a (forward) PrimerDesign ACCTCACAGATGCCAAGCC
Col1a (reverse) PrimerDesign ATCTGGGCTGGGGACTGAG
Gapdh (forward) PrimerDesign Not disclosed
Gapdh (reverse) PrimerDesign Not disclosed
Dmp1 (forward) Ambion Not disclosed
Dmp1 (reverse) Ambion Not disclosed
Sost (forward) Ambion Not disclosed
Sost (reverse) Ambion Not disclosed
doi:10.1371/journal.pone.0036786.t001
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matrix mineralization may irreversibly modify osteoblast behav-
iour to limit osteocytogenesis, the capacity of MLO-A5 cells to re-
enter the osteocyte differentiation programme was also measured,
by first restricting and then later promoting ECM mineralization
by modifying the medium. PPi was omitted from the fresh medium
which was added on day 6, or the cultures that had been treated
with medium lacking bGP were later replenished with medium
supplemented with bGP. The cells were then grown as previously
described for a further 9 days before analysis.
Assessment and quantification of matrix mineralization
Briefly, cells were washed with phosphate-buffered saline (PBS),
and then fixed with 4% paraformaldehyde (PFA) for 5 min at 4uC.
After several washes in PBS, cell layers were stained with aqueous
2% (w/v) Alizarin red solution (Sigma) at pH 4.2, for 5 minutes at
room temperature, before washing with water, to remove any
unbound stain. A photomicrographic image of each culture well was
captured to record the distribution of mineral staining, the bound
stain subsequently solubilized in 10% cetylpyridinium chloride
(Sigma) and the optical density of the resultant solution determined
at 570 nm by spectrophotometry (Thermo Multiskan Ascent).
RNA Extraction and Comparative Real-time PCR
Total RNA was extracted from MLO-A5 cells using Tri-Reagent
(Ambion, Huntingdon UK) according to the manufacturer’s
instructions. After extraction, RNA was precipitated with isopro-
panol, washed in ethanol and then resuspended in nuclease-free
water. Purified RNA was treated with DNase (Ambion) and stored at
280uC. RNA samples (and controls consisting of RNase-free water)
were reverse-transcribed into cDNA using Superscipt II reverse
Figure 1. Mineralization and E11 expression by the MLO-A5 cell line. (A) Alizarin red staining of MLO-A5 cultures over a 15-day time-course.
(B) Quantification of Alizarin red staining by spectrophotometry. (C) E11 mRNA expression in the MLO-A5 cultures as determined by qRT-PCR. (D)
Akp2 mRNA expression in MLO-A5 cultures. (E) E11 protein (,38 kDa) expression by MLO-A5 cells. b-actin was used as a loading control. (F)
Densitometric analysis of 3 independent E11 western blots. Results are mean6SEM (n= 3). * P,0.05, ** P,0.01, *** P,0.001 compared with previous
time-point (B) or day 0 (C and F).
doi:10.1371/journal.pone.0036786.g001
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transcriptase (Invitrogen) according to the manufacturer’s instruc-
tions. Real-time PCR (RT-qPCR) was carried out in a Stratagene
Mx3000P cycler and each reaction contained 50 ng template DNA,
250 nM forward and reverse primers (Table 1) and 1xFastStart
Universal SYBR Green Master Mix (Roche, East Sussex UK).
Samples were amplified using the following program; an initial step
of 50uC for 2 minutes and 95uC for 2 minutes (1 cycle) followed by
95uC for 15 seconds and 60uC for 30 seconds (40 cycles) and a final
step of 95uC for 1 minute, 60uC for 30 seconds, 95uC for 15 seconds
and 25uC for 30 seconds (1 cycle). The Ct values for the samples
were normalised to that of Gapdh, which was determined to be the
most stable housekeeping gene for these experiments (data not
shown), and the relative expression was calculated using the DDCt
method [29]. The amplification efficiencies of all the primers were
between 90–100%.
Western Blotting
Protein lysates were extracted from MLO-A5 cells in RIPA
buffer (150 mM NaCl, 1.0% IGEPALH CA-630, 0.5% sodium
deoxycholate, 0.1% SDS, 50 mM Tris, pH 8.0) (Sigma) contain-
ing protease inhibitors (Roche). Protein concentrations were
determined using the DC assay (Bio-Rad, Hemel Hempsted,
UK) and 15 mg of protein was separated using a 10% bis-tris gel
and then transferred to a nitrocellulose membrane and probed
with goat anti-mouse E11 (1:1000, R&D Systems) and HRP-linked
rabbit anti-goat secondary antibody (1:5000, Dako, Cambridge,
UK), diluted in 5% non-fat milk (Marvel, Lincs UK). Membranes
were washed in TBST and the immune complexes visualised by
chemiluminescence using the ECL detection kit and an ECL film-
based technique (GE Healthcare, Amersham, UK). Equal loading
of protein was confirmed by stripping the blot in Restore Western
stripping buffer (Pierce, Rockford, USA) for 30 minutes at 37uC
and subsequent re-probing with HRP-conjugated anti b-actin
antibody (1:25000, Sigma) for 60 minutes. Densitometric analysis
was performed using Quantity One software (Bio-rad, UK).
Measurement of Collagen Production
After fixation in 4% PFA, cell layers were stained with ‘Sircol’
dye reagent (Sirius red and picric acid, Biocolor Ltd, County
Antrim, UK) for 1 hour at room temperature. Unbound dye was
removed with 0.001 M HCl, the matrix-bound stain solubilised in
0.1 M NaOH and absorbance measured at 570 nm.
Statistical Analysis
Data are expressed as the mean 6 SEM of at least 3
experiments. Statistical analysis was performed by one way
analysis of variance (ANOVA) – general linear model. P,0.05
was considered to be significant and noted ‘*’; P values of ,0.01
and ,0.001 were noted as ‘**’ and ‘***’ respectively.
Results
Matrix mineralization and E11 Expression in MLO-A5 cell
cultures
Alizarin red staining was initially evident on day 3 of culture
(Figures 1A and B), increased on days 6 and 9, but showed no
further increases thereafter. These studies are in agreement with
previously published data [27] and confirm that mineralization of
Figure 2. Osteocytic differentiation of the MLO-A5 cell line. The temporal expression patterns of the osteocyte-marker genes Dmp1 (A), Phex
(B), Cd44 (C) and Sost (D) as assessed by qRT-PCR. Results are mean6SEM (n= 3). * P,0.05, ** P,0.01, *** P,0.001 compared to day 0.
doi:10.1371/journal.pone.0036786.g002
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the MLO-A5 cell cultures was initiated by day 3 and almost
complete by day 9.
E11 mRNA levels were detectable at day 0 of MLO-A5 cell
culture, increasing concomitantly with matrix mineralization at
days 3, 6 and 9, at which time E11 mRNA expression levels
reached an apparent plateau (Figure 1C). A similar temporal
pattern of expression was also observed for E11 protein levels
(Figure 1E and F), although E11 protein expression was not
observed at day 0 of culture. In contrast, although the MLO-A5
cells were found to express mRNA for tissue non-specific alkaline
phosphatase (Akp2), as previously observed by Kato et al. [27], no
obvious change in the temporal expression pattern ofAkp2 mRNA
was observed during the entire 15-day culture period (Figure 1D).
Increases in MLO-A5 cell expression of Dmp1, Phex, Sost and Cd44
mRNA was also noted during acquisition of an osteocyte-like
phenotype by MLO-A5 cells at more advanced stages of
mineralization (Figure 2). This temporal profile in gene expression
was also observed in mineralizing primary calvarial osteoblasts
(Figure 3) confirming the suitability of the MLO-A5 cell line as
a model to study osteocytogenesis. Together these results indicate
that under mineralizing conditions MLO-A5 cells differentiate into
an E11-expressing osteocyte-like phenotype.
ECM mineralization is required for E11 expression
To further explore the link between E11 expression and ECM
mineralization first proposed by Irie et al. [25], we constrained in
vitro mineralization by two different approaches; by either adding
PPi, the natural mineralization inhibitor, or by omitting bGP, the
phosphate donor from the culture medium. Predictably, both
approaches resulted in marked ablation of mineralization in the
MLO-A5 cell cultures, with a greater than 15-fold (P,0.001)
suppression in mineral deposition (Figures 4A and B). Under these
PPi-supplemented conditions or in the absence of bGP, we found
that E11 protein expression levels in MLO-A5 cells were
Figure 3. Osteocytic differentiation of primary calvarial osteoblasts in vitro. The temporal expression patterns of the osteocyte marker
genes, E11 (A), Dmp1 (B), Phex (C), Sost (D) and Cd44 (E) as assessed by qRT-PCR over 28 days of culture. (F) Mineralization of the primary osteoblast
cultures as assessed by Alizarin red staining. Results are mean6SEM (n= 4). * P,0.05, ** P,0.01, *** P,0.001 compared to day 0.
doi:10.1371/journal.pone.0036786.g003
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significantly reduced compared to control cultures. This reduction
in E11 protein expression was more marked in the PPi
supplemented cultures (Figures 4E and F). E11 mRNA expression
levels were also significantly reduced in the absence of mineral-
ization achieved by either of these two approaches (Figure 4D).
Intriguingly, however, E11 mRNA expression was observed in
MLO-A5 cells even in cultures where mineralization was
completely absent; thus, qRT-PCR Ct values of 26–27 were
evident despite negligible E11 protein and mineralization. These
findings suggest that E11 mRNA is still expressed in the
Figure 4. Inhibition of matrix mineralization in the MLO-A5 cell-line. (A) Alizarin red staining of MLO-A5 cultures in which mineralization was
inhibited by the addition of PPi or the omission of bGP and quantified by spectrometry (B). (C) Quantification of the collagenous matrix produced by
the MLO-A5 cell after 9 days of culture as demonstrated by Sirius red staining (D) E11 mRNA expression in the mineralization-inhibited MLO-A5 cell
cultures. (E) E11 protein expression in mineralization-inhibited and control MLO-A5 cultures as demonstrated by western blotting (F) Densitometric
analysis of the protein expression at day 9 in 3 independent E11 western blots. Results are mean6SEM (n= 3). ** P,0.01, *** P,0.001 compared to
day 0 (B) or AA & bGP (D and F) cultures.
doi:10.1371/journal.pone.0036786.g004
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mineralization-inhibited cultures, even though the protein is not
(Figures 4E and F), and is consistent with the time course of E11
mRNA and protein expression shown in Figures 1C and E.
Measurement of matrix-bound deposition of collagen showed that
the inhibition of matrix mineralization induced by either omission
of bGP or supplementation with PPi was not associated with any
marked impairment of collagen synthesis, which was unaffected
under either of these conditions (Figure 4C).
To investigate whether the presence of Pi alone is sufficient to
drive E11 expression, MLO-A5 cells were cultured in the presence
of AA and bGP (control) or with bGP alone. As expected, the
cultures supplemented with bGP alone demonstrated reduced
mineral deposition compared to control cultures, although some
evidence of dystrophic mineralization was present, even in the
absence of ascorbic acid-induced collagen secretion (Figure 5A).
Limited E11 protein expression was also observed in the cultures
supplemented with only bGP (Figure 5B and 5C) but this was
significantly less than the amount of E11 expressed by the cultures
supplemented with AA and bGP. This suggests that the deposition
of mineral within the ECM is required to fully drive E11
expression and osteocyte differentiation.
ECM mineralization is required for osteoblast-to-
osteocyte transition
We have shown that the expression levels of several osteocyte
marker genes are increased during osteocytic differentiation and
matrix mineralization by MLO-A5 cells in vitro (Figure 2). To
confirm whether inhibition of mineralization (by adding PPi or
omitting bGP) also negatively regulates expression of these genes, as
had been shown for E11 mRNA levels, we measured the expression
of a panel of osteocyte marker genes (Sost, Phex, Dmp1 and Cd44) by
RT-qPCR after 9 days of culture. We found that the levels of all of
these genes was decreased in cultures either lacking bGP, or
supplemented with PPi, compared to control cultures supplemented
with both AA andbGP (Figures 6 A–D). Decreased level of osteocyte
marker genes in these MLO-A5 cells suggests that matrix
mineralization is required for the transition from a mature osteoblast
to an osteocyte-like phenotype. The likelihood that the lack of
mineralization is sufficient to block this osteocytogenesis in vitro was
confirmed by analyzing osteoblast-marker gene expression, which
showed that the levels of osteocalcin (Ocn) and collagen type I alpha
(Col1a) mRNA were both elevated in these cultures where
mineralization had been inhibited by either exogenous PPi or by
omission of bGP (Figures 6E and F).
Recovery of in vitro mineralization by MLO-A5 cells
It is possible that MLO-A5 cells undergo some irreversible
change in cell behaviour in response to inhibition of mineraliza-
tion. If this were indeed the case, then it would be possible that the
suppression of E11 expression may not be directly linked to
mineralization status. We therefore determined whether MLO-A5
cells were capable of recovering both their mineralization potential
and E11 expression after periods of inhibited matrix mineraliza-
tion. As expected, Alizarin red staining was completely lacking
after treatment for 6 days with PPi or culture in the absence of
bGP (Figure 7A). In contrast, some albeit limited mineralization
was seen by day 9, 3 days after the cessation of inhibition upon
return to culture conditions that promote differentiation. Evidence
for such recovery in mineralization increased with more prolonged
culture, but yet failed to reach control levels even at days 12 or 15
(Figure 7B). Furthermore, the link between modified mineraliza-
tion status and E11 expression was strengthened by the
observations that such re-initiation of mineralization was in-
timately associated with increased E11 expression (Figures 7C and
D). These data further strengthen the connection between the
mineralization of MLO-A5 cell cultures and the expression of E11.
Discussion
The density, integrity and three-dimensional organisation of the
osteocyte canalicular network are important in the etiology of
various skeletal disorders such as osteoporosis and osteomalacia
[30]. Such changes suggest a cellular basis for many bone diseases
and it is therefore essential that we understand more fully the
processes and genetic circuitry responsible for the terminal
differentiation of osteoblasts to osteocytes. Although, the mechan-
isms which govern these osteocytogenic processes are unknown,
several models of osteocyte differentiation have been proposed [3–
5,31]. Such models, applicable to both intramembranous and
endochondral ossification, have proposed that the osteocyte has
a predominantly passive role [31,32]. Other evidence, however,
has suggested that the embedding of an osteocyte is an active,
invasive process [6]. Indeed, it is possible to speculate that the
Figure 5. Effect of inorganic phosphate supplementation on
MLO-A5 cultures. Matrix mineralization (A) and E11 protein
expression (B) after 9 days in control (AA and bGP) MLO-A5 cultures
and cultures in which AA was omitted (bGP only). (C) Densitometric
analysis of 3 independent E11 western blots. Results are mean6SEM
(n = 3). ** P,0.01 compared to AA & bGP cultures.
doi:10.1371/journal.pone.0036786.g005
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dramatic morphological and genetic transformations observed
during osteocytogenesis, reflect a tightly regulated, active process
that does not merely involve the osteoblast simply becoming
trapped, without an inherent contribution, within the ECM.
The role of the mineralized ECM in the regulation of osteocyte
development is now becoming more fully recognised. Mineraliza-
tion of lamellar bone occurs at the late osteoblast/pre-osteocyte
stage and it has been suggested that ECM mineralization is part of
the process that transforms pre-osteocytes into mature osteocytes
[17]. This is supported by data showing a positive correlation
between ECM mineralization and osteocyte number [8,33–35].
These in vivo-based observational studies cannot, however, entirely
rule out the possibility that defective osteocyte maturation/
morphology may lead to changes in bone mineralization. For this
reason, the present study has exploited a carefully defined,
controlled in vitro model system in which the MLO-A5 cell-line
effectively models late-stage osteoblastic differentiation to in-
vestigate whether mineralization of the surrounding ECM acts as
a trigger for osteocyte maturation.
Inhibition of ECM mineralization using two distinct strategies
resulted in a striking impairment of E11 protein expression. These
impaired E11 levels were apparent even at late stages of the 15-day
long culture period, when strong E11 protein expression would
normally have been be expected. It was apparent that inhibition of
mineralization using PPi also resulted in a marked suppression of
E11 expression, greater than achieved by the omission of bGP
alone, therefore suggesting that presence of PPi inhibits E11
protein expression. It has previously been shown that E11
expression is required for the elongation of osteocyte cellular
processes [15] and that mineralization occurs along the processes
produced by differentiating MLO-A5 cells [17] and primary
osteoblasts [33,36]. Our studies strengthen this link between E11-
Figure 6. Effect of ECM mineralization inhibition on the expression of osteocyte and osteoblast marker genes in MLO-A5 cells. Sost
(A), Phex (B), Dmp1 (C), Cd44 (D), Ocn (E) and Col1a (F) mRNA expression in the mineralization-inhibited cultures as quantified by RT-PCR. Results are
mean6SEM (n= 3). * P,0.05, ** P,0.01, *** P,0.001 compared to AA & bGP cultures.
doi:10.1371/journal.pone.0036786.g006
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mediated process formation and ECM mineralization. The
relative lack of E11 protein in cultures in which mineralization
has been inhibited is suggestive of a block in MLO-A5
differentiation toward the osteocyte phenotype. This was con-
firmed by the decreased expression of the osteocyte-marker genes
Dmp1, Phex, Sost and Cd44 by MLO-A5 under mineralization-
inhibited conditions; conversely, the expression of the osteoblast-
marker genes Col1a and Ocn was increased. Taken together, these
data strongly suggest that inhibition of mineralization promotes
retention of a late-osteoblast stage of differentiation and prevents
osteocytic differentiation. An unexpected observation was the
decreased expression of Sost, while E11, DMP1 and Phex
increase, during mineralisation in both primary and MLO-A5
cell cultures. This is currently unexplained but its examination
may give clues to the mechanism by which Sost expression is
regulated. Future studies may also broaden this strategy to include
bone markers known to regulate ECM mineralization, such as
other SIBLINGs (BSP, OPN) and OCN.
The mechanism by which ECM mineralization promotes
osteocytic differentiation is presently unknown. The osteocyte
has been shown, however, to be highly responsive to changes in its
mechanical environment [1,37–39]. Indeed, primary cilia de-
scribed on both osteoblasts and osteocytes [40] are known to play
important roles in transducing external mechanical cues, derived
either directly or indirectly from the ECM, into intracellular
responses essential for processes such as differentiation [40–42]. It
has also been reported that subjecting pre-osteoblasts and
osteoblasts to hypoxic conditions in vitro leads to increased
expression of osteocyte-markers [43]. It seems reasonable to
assume therefore that mineralized matrices, which are more
hypoxic than non-mineralized osteoid, may positively influence
osteocytogenesis in vivo. Maintenance of MLO-A5 cells in hypoxia
resulted in decreased mineralization compared to cells cultured
under normoxic conditions, however, indicating that this effect
may also depend on the stage of differentiation [44].
Interestingly, increased E11 protein was observed in osteocytes
from the DMP1-null mouse, which is characterized by diffuse
osteomalacia and reduced mineral density [13]. It is important to
note, however, that although the bone from these mice is
hypomineralized, mineral is still present within the matrix and
could potentially drive E11 expression. Indeed, in wild-type mice,
E11 protein expression in cortical bone is localized to the
immature osteocytes within newly-mineralizing osteoid [15]. Such
newly-synthesized bone would be expected to have a lower
mineral density than the more mature bone, similar to the
hypomineralized bone of the DMP1-null mouse. Therefore, the
gradient of mineral density and matrix maturation may regulate
E11 expression. Also, in the DMP1-null mouse, other factors such
as increased alkaline phosphatase and FGF23 levels may affect
E11 expression independent of ECM mineralization.
Figure 7. Effect of reversal of ECM mineralization inhibition on MLO-A5 cells. (A) Alizarin red staining of MLO-A5 cultures in which
mineralization was inhibited for 6 days before being promoted for a further 9 days. (B) Quantification of the results from (A) by spectrometry. Results
are mean6SEM (n= 3). (C) E11 protein expression under the same conditions as (A) and (B). (D) Densitometric analysis of 3 independent E11 western
blots. Results are mean6SEM (n= 3). *P,0.05, **P,0.01, ***P,0.001 compared to previous time-point.
doi:10.1371/journal.pone.0036786.g007
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A recent study by Zhang et al. [45] found that restoration of
serum Pi levels in DMP1-null mice, partially rescued the negative
effect on osteocyte differentiation observed in this mouse model.
This was also accompanied by a decrease in osteoid volume,
suggesting partial restoration of mineralization. However, discrim-
inating if the presence of Pi alone is sufficient to drive
osteocytogenesis, or whether its incorporation into the ECM as
hydroxyapatite is required for osteocyte maturation, has not been
fully explored. Our results using bGP as a source of phosphate
suggest that its presence alone, without a collagenous matrix, can
induce limited expression of the osteocyte marker E11. However,
this level of expression is significantly less that that observed when
the cells are also cultured with AA, enabling the synthesis and
secretion of a collagenous ECM. Therefore, both the bio-
availability of Pi and its deposition within the ECM appear to
be essential for osteocyte differentiation.
E11 has previously been described as the earliest osteocyte
marker during osteoblast-osteocyte transition [15,17]. Our studies
indicate that E11 is also intimately regulated by the ECM
mineralization status. It is important to note, however, that these
studies have taken place in a 2D model system which may not be
fully representative of the in vivo bone environment, and that our
attempts to test this through shRNA-mediated knockdown in
MLO-A5 cells have not been successful in blocking E11
expression. Although further studies are required to better define
the mechanisms that control transcription, translation and post-
translational stability of the E11 protein, these results emphasise
the influence of physiological ECM-cell interactions on osteoblast
differentiation and importantly suggest that ECM mineralization is
essential for terminal osteoblast differentiation to the osteocyte
phenotype.
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